Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adanif XL 30mg tablets
0206020R0CIAAAN
|
Adanif | Nifedipine | Cardiovascular System | 658 |
|
Valni 20 Retard tablets
0206020R0CFAAAR
|
Valni | Nifedipine | Cardiovascular System | 640 |
|
Fortipine LA 40 tablets
0206020R0BXAAAX
|
Fortipine | Nifedipine | Cardiovascular System | 616 |
|
Valni XL 60mg tablets
0206020R0CFACAP
|
Valni | Nifedipine | Cardiovascular System | 595 |
|
Adalat retard 20mg tablets
0206020R0BBAFAR
|
Adalat | Nifedipine | Cardiovascular System | 516 |
|
Adanif XL 60mg tablets
0206020R0CIABAP
|
Adanif | Nifedipine | Cardiovascular System | 322 |
|
Adalat LA 60mg tablets
0206020R0BBAIAP
|
Adalat | Nifedipine | Cardiovascular System | 209 |
|
Neozipine XL 30mg tablets
0206020R0CHAAAN
|
Neozipine | Nifedipine | Cardiovascular System | 179 |
|
Neozipine XL 60mg tablets
0206020R0CHABAP
|
Neozipine | Nifedipine | Cardiovascular System | 178 |
|
Nifedipine 5mg/5ml oral suspension
0206020R0AABRBR
|
Nifedipine | Nifedipine | Cardiovascular System | 165 |
|
Nifedipine 10mg/5ml oral suspension
0206020R0AABQBQ
|
Nifedipine | Nifedipine | Cardiovascular System | 122 |
|
Adalat retard 10mg tablets
0206020R0BBAGAE
|
Adalat | Nifedipine | Cardiovascular System | 106 |
|
Dexipress MR 20mg tablets
0206020R0CKAAAR
|
Dexipress | Nifedipine | Cardiovascular System | 101 |
|
Adalat LA 20mg tablets
0206020R0BBAJAR
|
Adalat | Nifedipine | Cardiovascular System | 93 |
|
Nifedipine 20mg/ml oral drops
0206020R0AAASAS
|
Nifedipine | Nifedipine | Cardiovascular System | 78 |
|
Nidef 30mg modified-release tablets
0206020R0CJAAAN
|
Nidef | Nifedipine | Cardiovascular System | 68 |
|
Nidef 60mg modified-release tablets
0206020R0CJABAP
|
Nidef | Nifedipine | Cardiovascular System | 55 |
|
Nifedipress MR 20 tablets (Teva)
0206020R0CBAEAR
|
Nifedipress | Nifedipine | Cardiovascular System | 29 |
|
Adalat 10mg capsules
0206020R0BBABAB
|
Adalat | Nifedipine | Cardiovascular System | 20 |
|
Nifedipine 2.5mg/5ml oral suspension
0206020R0AABKBK
|
Nifedipine | Nifedipine | Cardiovascular System | 19 |
|
Nifedipress MR 10 tablets (Teva)
0206020R0CBACAE
|
Nifedipress | Nifedipine | Cardiovascular System | 14 |
|
Adalat 5mg capsules
0206020R0BBAAAA
|
Adalat | Nifedipine | Cardiovascular System | 6 |
|
Nifedipine 100mg/5ml oral suspension
0206020R0AAAUAU
|
Nifedipine | Nifedipine | Cardiovascular System | 1 |
|
Nifedipress MR 20 tablets (Actavis)
0206020R0CBADAR
|
Nifedipress | Nifedipine | Cardiovascular System | 1 |
|
Nifopress MR 20mg tablets
0206020R0CEABAR
|
Nifopress | Nifedipine | Cardiovascular System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.